|
|
|
|
| Phase-Appropriate Signal Detection In Clinical Trials | White Paper | By Dr. Mohit Raizada, IQVIA Safety & Regulatory Compliance | Are your trial safety methods right for your phase? Learn a framework that keeps medical judgment central, avoids overreading sparse early data and catches rarer risks as studies grow. |
|
|
|
|
|
|
| DCT Benefits Are Proven, Yet Progress Is Slow | From The Editor | By Dan Schell, Chief Editor, Clinical Leader | Despite the clear benefits of decentralized trials—broader reach, better retention, and higher diversity—adoption has been slow. In this interview, Sunny Kumar of Informed Ventures explains how AI is lowering costs, speeding up study builds, and pushing DCTs from fringe to future. |
|
|
| Running Decentralized Trials At Scale | Article | Catalent | Sponsors are recognizing the potential benefits of decentralized clinical trials, including reduced operational costs and improved recruitment and retention of more diverse patient populations. |
|
|
| Connect With Clinical Leader: |
|
|
|
